Northern Bitcoin AG

  • WKN: A0SMU8
  • ISIN: DE000A0SMU87
  • Land: Deutschland

Nachricht vom 29.06.2019 | 18:51

NORTHERN BITCOIN RECEIVES FINANCING OF EUR 8 MILLION

Northern Bitcoin AG / Key word(s): Miscellaneous
NORTHERN BITCOIN RECEIVES FINANCING OF EUR 8 MILLION

29-Jun-2019 / 18:51 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


AD HOC RELEASE

 

NORTHERN BITCOIN RECEIVES FINANCING OF EUR 8 MILLION

Frankfurt am Main, June 29, 2019. Northern Bitcoin AG (Xetra: NB2, ISIN: DE000A0SMU87) has received financing in the form of an EUR 8 million framework loan. The financing can be used flexibly, has a term until December 31, 2025 and further expands the Company's financial options.

Disclaimer:
This press release does not constitute an offer to sell or the solicitation of an offer to buy or subscribe for any securities of Northern Bitcoin AG and does not constitute a prospectus of Northern Bitcoin AG. The information contained in this press release is not intended to form the basis of any financial, legal, tax or other business decision. Investment or other decisions should not be made solely on the basis of this press release. As with all business and investment matters, please consult qualified professional advice. This release and the information contained herein are not for distribution, directly or indirectly, in or into Canada, Australia or Japan.

Press contact:
Northern Bitcoin AG
Dr. Hans Joachim Dürr
Head of Corporate Communications
Thurn-und-Taxis-Platz 6
60313 Frankfurt
Germany
E-Mail: h.duerr@northernbitcoin.com
Telefon: +49 69 348 752 89

Investor Relations:
Sven Pauly
E-Mail: ir@northernbitcoin.com
Telefon: +49 89 125 09 03 31


29-Jun-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC-Fokusbox

Expedeon AG mit attraktiver Produktpipeline

Durch die konsequente Fortsetzung der „Grow, Buy & Build“-Strategie hat die im Bereich der Entwicklung und Vermarktung von DNA-Technologien, Proteomik- und Antikörper-Konjugations-Anwendungen tätige Expedeon AG das Umsatzniveau angehoben und auf operativer Ergebnisebene zugleich den Break-Even nachhaltig überschritten. Für die kommenden Perioden ist der Ausbau der Umsatzerlöse mit den bestehenden Produkten geplant. Darüber hinaus verfügt die Expedeon AG über eine attraktive Produktpipeline mit hohem Umsatzpotenzial. Unser Kursziel liegt bei 3,20 € je Aktie. Das Rating lautet KAUFEN.

Aktuelle Research-Studie

ITM Power PLC

Original-Research: ITM Power Plc (von First Berlin Equity Research GmbH): Hinzufügen

15. Oktober 2019